Nextgen Biomed Ltd (NXGN)
Nov 10, 2023 - NXGN was delisted (reason: acquired by Thoma Bravo)
23.94
+0.03 (0.13%)
Inactive · Last trade price on Nov 8, 2023

NextGen Healthcare Balance Sheet

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
0.020.055.2411.965.67
Short-Term Investments
0.020.02--0.02
Cash & Short-Term Investments
0.040.075.2411.965.69
Cash Growth
-46.15%-98.76%-56.19%110.08%199.63%
Other Receivables
0.10.07-0.150.16
Receivables
0.10.07-0.150.16
Prepaid Expenses
0.060.010.010.160.05
Restricted Cash
0.030.08---
Total Current Assets
0.230.235.2512.275.9
Property, Plant & Equipment
0.310.03-0.010.01
Other Intangible Assets
--1.557.29-
Other Long-Term Assets
0.03---0.5
Total Assets
0.580.2614.8923.638.32
Accounts Payable
0.180.150.170.140.07
Accrued Expenses
2.51.021.090.730.63
Current Portion of Leases
0.11----
Other Current Liabilities
0.140.07--0.75
Total Current Liabilities
2.921.241.260.871.45
Long-Term Leases
0.12----
Other Long-Term Liabilities
--1.382.14-
Total Liabilities
3.041.242.643.011.45
Additional Paid-In Capital
67.0864.463.4357.9638.2
Retained Earnings
-70.94-66.05-51.86-43.29-40.74
Treasury Stock
-0.01-0.01-0.01-0.01-0.01
Comprehensive Income & Other
1.530.80.86.079.52
Total Common Equity
-2.34-0.8612.3620.726.97
Minority Interest
-0.12-0.12-0.11-0.1-0.1
Shareholders' Equity
-2.47-0.9812.2520.626.87
Total Liabilities & Equity
0.580.2614.8923.638.32
Total Debt
0.22----
Net Cash (Debt)
-0.190.075.2411.965.69
Net Cash Growth
--98.76%-56.19%110.08%199.63%
Net Cash Per Share
-0.020.010.731.801.05
Filing Date Shares Outstanding
10.97.297.227.226.34
Total Common Shares Outstanding
10.97.297.227.225.53
Working Capital
-2.7-1.013.9911.44.45
Book Value Per Share
-0.21-0.121.712.871.26
Tangible Book Value
-2.34-0.8610.8113.436.97
Tangible Book Value Per Share
-0.21-0.121.501.861.26
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q